The anomalous pharmacology of fentanyl
British Journal of Pharmacology · 2023-04 · 180 (7) · 797-812
DOI: 10.1111/bph.15573 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, online erschienen am 02.07.2021. Verfasst von Eamonn Kelly und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK. Hauptthemen laut MEDLINE: Fentanyl, Drug Overdose. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: Medical Research Council, Biotechnology and Biological Sciences Research Council (BBSRC), South West Biosciences (SWBio).
Abstract (Originalsprache)
Fentanyl is a key therapeutic, used in anaesthesia and pain management. It is also increasingly used illicitly and is responsible for a large and growing number of opioid overdose deaths, especially in North America. A number of factors have been suggested to contribute to fentanyl's lethality, including rapid onset of action, in vivo potency, ligand bias, induction of muscle rigidity and reduced sensitivity to reversal by naloxone. Some of these factors can be considered to represent ‘anomalous’ pharmacological properties of fentanyl when compared with prototypical opioid agonists such as morphine. In this review, we examine the nature of fentanyl's ‘anomalous’ properties, to determine whether there is really a pharmacological basis to support the existence of such properties, and also discuss whether such properties are likely to contribute to overdose deaths involving fentanyls. LINKED ARTICLES This article is part of a themed issue on Advances in Opioid Pharmacology at the Time of the Opioid Epidemic. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v180.7/issuetoc
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
ORCID-Profile: Eamonn Kelly, Katy Sutcliffe, Graeme Henderson
Förderung
- Medical Research Council
- Biotechnology and Biological Sciences Research Council (BBSRC)
- South West Biosciences (SWBio)
- Medical Research Council Canada
Zitieren
APA
Kelly, E., Sutcliffe, K., Cavallo, D., Ramos-Gonzalez, N., Alhosan, N., & Henderson, G. (2023). The anomalous pharmacology of fentanyl. British Journal of Pharmacology, 180(7), 797-812. https://doi.org/10.1111/bph.15573
Vancouver
Kelly E, Sutcliffe K, Cavallo D, Ramos-Gonzalez N, Alhosan N, Henderson G. The anomalous pharmacology of fentanyl. British Journal of Pharmacology. 2023;180(7):797-812. doi:10.1111/bph.15573
BibTeX
@article{Kelly2023,
author = {Kelly, Eamonn and Sutcliffe, Katy and Cavallo, Damiana and Ramos-Gonzalez, Nokomis and Alhosan, Norah and Henderson, Graeme},
title = {The anomalous pharmacology of fentanyl},
journal = {British Journal of Pharmacology},
year = {2023},
volume = {180},
number = {7},
pages = {797--812},
doi = {10.1111/bph.15573}
}
EUVIMED